Back to Top Skip to main content

Human Papillomavirus


IMPORTANT: The Defense Health Agency (DHA) is aware of the World Health Organization-recommended moratorium on vaccinating boys with HPV vaccine due to increased worldwide demand for this vaccine. However, the manufacturer of the only 9vHPV vaccine used in the United States reports that supply of vaccine in the United States is sufficient for all populations for whom the Advisory Committee on Immunization Practices (ACIP) currently recommends this vaccine. Therefore, DHA recommends that providers continue to follow current ACIP recommendations and offer the 9vHPV vaccine with no restrictions.


Human papillomavirus

Human papillomavirus (HPV) is a group of more than 150 related viruses. Each virus in this large group is given a number, which is called its HPV type. HPV is named for the warts (papillomas) some HPV types can cause. HPV causes cancers in both men and women, including cancer of the cervix, vulva, vagina, penis, or anus. HPV infection can also cause cancer in the back of the throat, including the base of the tongue and tonsils.  HPV is transmitted through intimate skin-to-skin contact. You can get HPV by having vaginal, anal, or oral sex with someone who has the virus. It is most commonly spread during vaginal or anal sex. HPV is so common that nearly all men and women get it at some point in their lives. HPV can be passed even when an infected person has no signs or symptoms. You can develop symptoms years after being infected, making it hard to know when you first became infected. Pregnant women can pass HPV onto their babies during birth, although this is not common.

In most cases, HPV goes away on its own and does not cause any health problems. But when HPV does not go away, it can cause health problems like genital warts and cancer.

Genital warts usually appear as a small bump or groups of bumps in the genital area. They can be small or large, raised or flat, or shaped like a cauliflower. A healthcare provider can usually diagnose warts by looking at the genital area.

HPV vaccine is important because it protects against cancer. Every year in the United States, HPV causes more than  34,000 cancers in men and women. HPV vaccination can prevent most of those cancers (about 90%) from occurring.  HPV vaccine is recommended for males and females 9 through 45 years of age.  All children who are 9 through 14 years old should receive two doses of HPV vaccine 6 to 12 months apart. Adolescents who receive their two doses less than five months apart will require a third dose of HPV vaccine. Anyone who is 15 years of age or older and receiving the vaccine for the first time should receive three doses of the HPV vaccine. The second dose of the vaccine should be received two months after the first dose, and the third dose should be received six months after the initial dose. Three doses are recommended for people 9 through 45 years of age with certain immunocompromising conditions, including HIV. Children and adults aged 9-26 years who did not start or finish the HPV vaccine series should get it now.  Adults aged 27-45 years should speak with their provider to see if catch-up vaccination is warranted.

These recommendations apply to all persons, regardless of behavioral or medical risk factors for HPV infection or disease.  Women who are pregnant should wait until after delivery to start or continue HPV vaccination.

Source: Centers for Disease Control and Prevention

You also may be interested in...

Human Papilloma Virus (HPV) and HPV Vaccines

Fact Sheet
12/17/2019

This information paper describes Human Papilloma Virus and the vaccine to prevent it.

Recommended Content:

Human Papillomavirus

Human Papillomavirus–Attributable Cancers — United States, 2012–2016

Report
8/23/2019

An average of 34,800 cancers reported annually in the United States during 2012–2016 were attributable to HPV. Of these, 92 percent were attributable to HPV types targeted by the 9-valent HPV vaccine.

Recommended Content:

Human Papillomavirus

MMQC-18-2189 Gardasil 9 Prefilled Syringes RECALL

Publication
8/29/2018

The manufacturer has issued a voluntary recall on Gardasil 9 prefilled syringes that are labeled with an incorrect lot number and expiration date.

Recommended Content:

Human Papillomavirus

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination

Report
12/16/2016

Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices

Recommended Content:

Human Papillomavirus | Vaccine Schedules

The HPV Vaccine Saves Lives

Infographic
5/16/2016
The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4). This graphic highlights information the benefits of the HPV vaccine. The vaccine is most effective among fully vaccinated individuals.   Cancer Prevention Facts •	HPV is the most common sexually  transmitted infection (STI) •	There are more than 40 HPV types that can infect the genital areas •	Some HPV types give warts •	Some HPV types develop cancer  Effective Against STI Transmission •	The HPV vaccine is a safe and effective way to protect yourself from the virus •	The HPV vaccine provides nearly 100% protection from HPV types 6,11,16 and 18 •	HPV vaccine shows early signs of success in reducing HPV infections and related illnesses •	Protection is expected to be long-lasting  Safety Tips •	Getting your HPV vaccine and practicing safe sex such as wearing a condom may lower the risk of HPV •	Limiting the number of lifetime sex partners can also lower the risk of HPV •	When given the HPV vaccine, the body makes antibodies in response to the protection to clear it from the body  Get the Facts •	2,091 female service members aged 17-26 years received 1-3 HPV4 doses during 2006-2012, stratified by number of doses (1, 2, or 3).  Get the HPV Vaccine •	Only 22.5% of eligible service members initiated the series •	Of those, only 39.1% completed the full three-dose series as of June 2011.  Even though the 3 dose regiment provides nearly complete protection against HPV16 and HPV18, in the U.S., only 12% and 19% of female adolescents among commercial and Medicaid plans respectively complete the series.  Read HPV Facts from the CDC: https://www.ok.gov/health2/documents/IMM_Teens_HPV_Facts.pdf  Read the STI issue of the Medical Surveillance Monthly Report at Health.Mil/MSMR   Get the conversation started. Ask your healthcare provider about the HPV vaccine today. Follow us on Twitter @AFHSBPAGE and use hashtag #VaccinesWork.

The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4).

Recommended Content:

Preventive Health | Immunizations | Men's Health | Human Papillomavirus | Armed Forces Health Surveillance Branch | Women's Health

Recommendations for the Use of Quadrivalent HPV Vaccines in the Navy and Marine Corps

Policy
  • Identification #: BUMED NOTICE 6230
  • Date: 12/10/2012
  • Type: Directives
  • Topics: Human Papillomavirus

COGARD Human Papillomavirus Vaccine for Males

Policy

Human Papillomavirus Vaccination Policy

Policy

Air Force Human Papillomavirus Vaccination Policy

ALCOAST Gardasil Human Papillomavirus Vaccine

Policy
Showing results 1 - 9 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.